- Global Pharma News & Resources

Press Releases - 2022-06-17

Date Title Company
17-Jun-2022 European Medicines Agency Commences Review of Aripiprazole 2-Month Long-Acting Injectable for the Maintenance Treatment of Schizophrenia in Adult Patients Stabilised with Aripiprazole Otsuka Pharmaceutical Europe Ltd.
17-Jun-2022 Spectral MD win Best Technology award at the European Mediscience Awards Spectral MD Holdings, Ltd.
17-Jun-2022 Tobias Leipold, CEO and Co-Founder, leaves eHealth-Tec GmbH Zur Rose Group AG
17-Jun-2022 Insulin Pens Market are rising at a CAGR of 4.4% by 2031 MARKITWIRED
17-Jun-2022 Single-Dose Radiotherapy Services Market to grow at 6.1% CAGR through 2030 MARKITWIRED
17-Jun-2022 Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market is predicted to increase at a high 7% CAGR over the forecast period 2022-2030 MARKITWIRED
17-Jun-2022 Electrophysiology Market to grow at 12.7% CAGR through 2030 MARKITWIRED
17-Jun-2022 Preparative and Process Chromatography Market Competitive Growth Strategies Based on Type, Applications, End User and Region MARKITWIRED
17-Jun-2022 Weekly Life Science News Round Up: 13th – 17th June PharmiWeb.Jobs
17-Jun-2022 Generis celebrates new milestones as swathes of the global pharma industry default to CARA Life Sciences™ to manage critical data and content Generis
17-Jun-2022 Surface Plasmon Resonance Market is expected to reach US$ 910.4 Mn in 2022, likely to surge at a vigorous 7.1% CAGR during 2022 – 29 – FMI MARKITWIRED
17-Jun-2022 Atopic Dermatitis Treatment Market is expected to reach US$ 7.6 Bn by 2029 | Research Report by FMI MARKITWIRED
17-Jun-2022 Americas COVID-19 Testing Market is expected to surpass US$ 7,264.4 Mn by 2031 | FMI MARKITWIRED
17-Jun-2022 Skincare Market covering Sales Outlook, Growth, Competitive Landscape, Segments , End-user – FMI MARKITWIRED
17-Jun-2022 Nasal Spray Market be valued at more than US$ 3.21 Billion by 2030 | Research Report by FMI MARKITWIRED
17-Jun-2022 New awards celebrate innovation in sustainable pharmaceutical packaging, winners announced at Connect in Pharma Sciad Newswire
17-Jun-2022 Formycon publishes Update on Development Projects Formycon AG
17-Jun-2022 Relief Therapeutics Files Amendment No. 3 to its Registration Statement on Form 20-F with the U.S. Securities and Exchange Commission Relief Therapeutics Holding SA